Strata Critical Medical, Inc.
SRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $49 | $71 | $54 | $54 |
| % Growth | -30.4% | 30.4% | -0.1% | – |
| Cost of Goods Sold | $38 | $53 | $42 | $42 |
| Gross Profit | $12 | $18 | $12 | $13 |
| % Margin | 23.6% | 25.1% | 22.1% | 23.2% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $11 | $20 | $17 | $19 |
| SG&A Expenses | $12 | $22 | $19 | $20 |
| Sales & Mktg Exp. | $0 | $2 | $1 | $1 |
| Other Operating Expenses | $5 | $0 | $0 | $0 |
| Operating Expenses | $17 | $23 | $20 | $21 |
| Operating Income | -$6 | -$5 | -$8 | -$8 |
| % Margin | -11.4% | -7% | -14% | -15.4% |
| Other Income/Exp. Net | -$4 | $1 | $4 | -$2 |
| Pre-Tax Income | -$10 | -$4 | -$4 | -$10 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | $57 | -$4 | -$3 | -$10 |
| % Margin | 116.5% | -5.3% | -6.4% | -18% |
| EPS | 0.7 | -0.046 | -0.04 | -0.12 |
| % Growth | 1,621.7% | -15% | 66.7% | – |
| EPS Diluted | 0.7 | -0.046 | -0.04 | -0.12 |
| Weighted Avg Shares Out | 82 | 81 | 80 | 79 |
| Weighted Avg Shares Out Dil | 82 | 81 | 80 | 79 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $2 | $2 | $2 |
| EBITDA | -$9 | -$3 | -$6 | -$7 |
| % Margin | -18.7% | -4.5% | -10.8% | -12.6% |